U.S. FDA approves laser phototherapy device for hair restoration in men

Theradome has received U.S. FDA clearance to market its LH80 PRO laser phototherapy hair restoration device to men.

Content Dam Bow Online Articles 2018 04 Gi 87788 Theradome

Medical device maker Theradome (Pleasanton, CA) has received U.S. FDA clearance to market its LH80 PRO laser phototherapy hair restoration device to men.

Related: Crowdfunding succeeds for at-home laser hair-growth device

Previously only available to women, the LH80 PRO Laser Helmet leverages laser phototherapy (also known as low-level laser light therapy) to stimulate weak hair follicles and provide them with targeted laser energy, which improves cellular metabolism and protein synthesis required to grow and maintain a healthy head of hair.

Content Dam Bow Online Articles 2018 04 Gi 87788 Theradome
Theradome's LH80 PRO Laser Helmet, which uses laser phototherapy to stimulate hair growth, is now U.S. FDA-approved for use by men.

The device, which produces results with two 20-minute treatments each week, uses 80 red lasers to generate over 440 J of energy and treat the full scalp area. The lasers delivers the optimum wavelength of light for hair growth (678 nm).

For more information, please visit www.theradome.com.

More in Biophotonics Tools